CRESCENT BIOPHARMA, INC. Stock Issued During Period, Shares, New Issues
CRESCENT BIOPHARMA, INC. (CBIO) reported Stock Issued During Period, Shares, New Issues of 3.48 million shares for the 1-month period ending 2016-06-30, per its 10-K filed 2017-03-01.
Discontinued
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2017-03-01
- 2016-06-30: Stock Issued During Period, Shares, New Issues 1 month 3.48M shares.
- 2016-03-28: Stock Issued During Period, Shares, New Issues 206.50K shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2016-06-30 | 3.48M shares 10-K · filed 2017-03-01 | |
| 2016-03-28 | 206.50K shares 10-Q · filed 2016-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |